Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Healthtrust
Cantor Fitzgerald
Federal Trade Commission
Moodys
Accenture
UBS
Queensland Health
Dow
Covington

Generated: February 22, 2018

DrugPatentWatch Database Preview

ONFI Drug Profile

« Back to Dashboard

When do Onfi patents expire, and what generic alternatives are available?

Onfi is a drug marketed by Lundbeck Pharms Llc and is included in two NDAs.

The generic ingredient in ONFI is clobazam. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the clobazam profile page.
Drug patent expirations by year for ONFI
Pharmacology for ONFI
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Mechanism of ActionCytochrome P450 2D6 Inhibitors

US Patents and Regulatory Information for ONFI

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms Llc ONFI clobazam SUSPENSION;ORAL 203993-001 Dec 14, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-003 Oct 21, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-001 Oct 21, 2011 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-002 Oct 21, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
Healthtrust
Dow
Baxter
Cantor Fitzgerald
Colorcon
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot